EGFR and lung carcinoma: Mutated EGFR is a major driver in lung cancer (Marchetti et al, 2005) and studies showed that cancer patients have an increased risk to develop severe COVID-19 and a threefold increased risk to die by a SARS-CoV-2 infection.